A Review on: Phase ‘0’ Clinical Trials or Exploratory Investigational New Drug
Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2017, Vol 14, Issue 1
Abstract
In a move to speed up the development of new medicines, the Food and Drug Administration announced in January 2006 the creation of the exploratory Investigational New Drug (IND), the so-called phase ‘0’ clinical trials. This guidance is intended to clarify what preclinical and clinical approaches, as well as chemistry, manufacturing, and controls information, should be considered when planning exploratory studies in humans, including studies of closely related drugs or therapeutic biological products, under an IND application (21 CFR 312). Existing regulations allow a great deal of flexibility in the amount of data that needs to be submitted with an IND application, depending on the goals of the proposed investigation, the specific human testing proposed, and the expected risks. The agency believes that sponsors have not taken full advantage of that flexibility and often provide more supporting information in INDs than is required by regulations. This guidance is intended to clarify what manufacturing controls, preclinical testing, and clinical approaches can be considered when planning limited, early exploratory IND studies in humans.
Authors and Affiliations
Ashish A. GAWAI, Faisal SHAIKH, Mangesh GADEKAR, Nitin DEOKAR, Shivanand KOLHE, K. R. BIYANI
Keywords
Related Articles
- EP ID EP380914
- DOI 10.4274/tjps.63935
- Views 143
- Downloads 0
Impact of Particle-Size Reduction on the Solubility and Antidiabetic Activity of Extracts of Leaves of Vinca rosea
Objectives: The present study aimed to enhance the aqueous solubility of methanol extract of leaves of Vinca rosea (family: Apocynaceae) by particle-size reduction using milling and to evaluate its antidiabetic activity....
The Effect of Sumatriptan in Ischemic Conditions in the Rat Heart
Objectives: The aim of this study was to investigate the effect of SUM on IR-induced injury in rat heart and its effect on IPC-induced protection. Materials and Methods: The rats were randomly divided into four groups: I...
Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals
Objectives: Pharmaceutical cocrystals are a promising tool to enhance the solubility and dissolution of poorly soluble drugs. Zaltoprofen (ZFN) is nonsteroidal anti-inflammatory drug with a prevalent solubility problem....
Phytochemical Screening and Toxicological Evaluation of Sargassum wightii Greville in Wistar Rats
Objectives: The present study was conducted to identify the phytoconstituents present in different extracts of Sargassum wightii and to assess the toxicity of its ethanol extract. Materials and Methods: Successive solven...
Formulation Design of Hydrocortisone Films for the Treatment of Aphthous Ulcers
Objectives: Research and development in oral drug delivery has evolved to the changeover of solid dosage forms from tablets to oral films. These films offer an elegant route for systemic drug delivery, with an advantage...